Kopran Q4 Results
- BSE: 524280
- NSE: KOPRAN
- ISIN: INE082A01010
- Sector: Biotechnology & Drugs
BSE
206.90
-0.60 (-0.29%)
-0.60 (-0.29%)Volume11.83 K
Updated: Wed 15 Jul, 2026 | 15:29:48
NSE
204-3.28 (-1.58%)
-3.28 (-1.58%)Volume99.89 K
Updated: Wed 15 Jul, 2026 | 15:29:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹234.02 Cr.(35.77%)
- Operating Profit₹36.06 Cr.(157.24%)
- Profit After Tax₹18.87 Cr.(94.95%)
- Operating Margin15.41%(89.47%)
Note: Comparison is on YoY basis
Quarterly - Kopran Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 197.96 | 178.46 | 10.93% | 167.98 | 25.02% |
| Depreciation/ Amortization | 4.52 | 4.42 | 2.26% | 3.59 | 16.72% |
| Operating Income | 36.06 | 15.82 | 127.95% | 18.10 | 157.24% |
| Net Income | 18.87 | 9.34 | 101.99% | 18.62 | 94.95% |
| Other Operating Expenses Total | 30.45 | 26.42 | 15.22% | 23.66 | 39.31% |
| Net Income Before Taxes | 25.35 | 10.74 | 135.92% | 25.18 | 84.87% |
| Total Revenue | 234.02 | 194.28 | 20.45% | 186.08 | 35.77% |
| Selling/ General/ Admin Expenses Total | 16.46 | 16.57 | -0.67% | 12.92 | -4.67% |
| Diluted Normalized EPS | 3.91 | 1.93 | 102.59% | 3.86 | 95.22% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.